BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27345127)

  • 21. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Exploratory study on detection of drug resistance of
    Liu YY; Shi J; Chu P; Wu TY; Li L; Pang Y; Lu J; Guo YL
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):552-559. PubMed ID: 35658379
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyrosequencing for rapid detection of Mycobacterium tuberculosis second-line drugs and ethambutol resistance.
    Lacoma A; Molina-Moya B; Prat C; Pimkina E; Diaz J; Dudnyk A; García-Sierra N; Haba L; Maldonado J; Samper S; Ruiz-Manzano J; Ausina V; Dominguez J
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):263-9. PubMed ID: 26256417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
    Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.
    Simons SO; van der Laan T; de Zwaan R; Kamst M; van Ingen J; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):828-33. PubMed ID: 26056110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Performance of the GenoType MTBDR
    Liu Q; Li GL; Chen C; Wang JM; Martinez L; Lu W; Zhu LM
    Chin Med J (Engl); 2017 Jul; 130(13):1521-1528. PubMed ID: 28639565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TB-EFI, a novel 18-Plex microbead-based method for prediction of second-line drugs and ethambutol resistance in Mycobacterium tuberculosis complex.
    Klotoe BJ; Molina-Moya B; Gomes HM; Gomgnimbou MK; Oliveira Suzarte L; Féres Saad MH; Ali S; Dominguez J; Pimkina E; Zholdybayeva E; Sola C; Refrégier G
    J Microbiol Methods; 2018 Sep; 152():10-17. PubMed ID: 29913189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of MTBDRplus and MTBDRsl in Detecting Drug-Resistant Tuberculosis in a Chinese Population.
    Lu W; Feng Y; Wang J; Zhu L
    Dis Markers; 2016; 2016():2064765. PubMed ID: 27524852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
    Tagliani E; Cabibbe AM; Miotto P; Borroni E; Toro JC; Mansjö M; Hoffner S; Hillemann D; Zalutskaya A; Skrahina A; Cirillo DM
    J Clin Microbiol; 2015 Sep; 53(9):2961-9. PubMed ID: 26179309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AID TB resistance line probe assay for rapid detection of resistant Mycobacterium tuberculosis in clinical samples.
    Molina-Moya B; Lacoma A; Prat C; Diaz J; Dudnyk A; Haba L; Maldonado J; Samper S; Ruiz-Manzano J; Ausina V; Dominguez J
    J Infect; 2015 Apr; 70(4):400-8. PubMed ID: 25305498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol].
    Chikamatsu K; Aono A; Yamada H; Mitarai S
    Kekkaku; 2012 Oct; 87(10):641-7. PubMed ID: 23214120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility testing to second-line drugs and ethambutol by GenoType MTBDRsl and Bactec MGIT 960 comparing with agar proportion method.
    López-Roa P; Ruiz-Serrano MJ; Alcalá L; García-Escribano Ráez N; García de Viedma D; Bouza E
    Tuberculosis (Edinb); 2012 Sep; 92(5):417-21. PubMed ID: 22698869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the GenoType MTBDRsl V 2.0 for detecting second-line drugs resistance of Mycobacterium tuberculosis isolates in Tunisia.
    Bouzouita I; Draoui H; Cabibbe AM; Essalah L; Bejaoui S; Trovato A; Messadi F; Cirillo DM; Slim-Saidi L
    Res Microbiol; 2021; 172(3):103816. PubMed ID: 33737037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis.
    Pérez-García F; Ruiz-Serrano MJ; López Roa P; Acosta F; Pérez-Lago L; García-De-Viedma D; Bouza E
    J Microbiol Methods; 2017 Aug; 139():74-78. PubMed ID: 28511895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic predictive values of the Hain genotype MTBDRsl assay in mycobacterial strains isolated from Sudan.
    Adam MAM; Ali HMH; Khalil EAG
    Pan Afr Med J; 2019; 32():124. PubMed ID: 31236189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.
    Ignatyeva O; Kontsevaya I; Kovalyov A; Balabanova Y; Nikolayevskyy V; Toit K; Dragan A; Maxim D; Mironova S; Kummik T; Muntean I; Koshkarova E; Drobniewski F
    J Clin Microbiol; 2012 May; 50(5):1593-7. PubMed ID: 22378910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory.
    Pillay S; de Vos M; Derendinger B; Streicher EM; Dolby T; Scott LA; Steinhobel AD; Warren RM; Theron G
    Clin Infect Dis; 2023 Feb; 76(3):e920-e929. PubMed ID: 35788278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
    Kardan-Yamchi J; Amini S; Hamzelou G; Rahimi Foroushani A; Ghodousi A; Cirillo DM; Feizabadi MM
    Arch Microbiol; 2021 Sep; 203(7):3989-3996. PubMed ID: 34032874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of the genotype MTBDRsl assay for rapid diagnosis of extensively drug-resistant tuberculosis in HIV-coinfected patients.
    Kontsevaya I; Ignatyeva O; Nikolayevskyy V; Balabanova Y; Kovalyov A; Kritsky A; Matskevich O; Drobniewski F
    J Clin Microbiol; 2013 Jan; 51(1):243-8. PubMed ID: 23152552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.